about
Stimuli-Responsive Polymeric Systems for Controlled Protein and Peptide Delivery: Future Implications for Ocular DeliveryNeuroprotection as a Therapeutic Target for Diabetic RetinopathySodium dependent multivitamin transporter (SMVT): a potential target for drug deliveryNonionic surfactant vesicles in ocular delivery: innovative approaches and perspectivesLiposomes and nanotechnology in drug development: focus on ocular targetsBiocompatibility and biodegradation studies of subconjunctival implants in rabbit eyesA biodegradable, sustained-released, prednisolone acetate microfilm drug delivery system effectively prolongs corneal allograft survival in the rat keratoplasty modelBimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluationSustained Antibiotic-Eluting Intra-Ocular Lenses: A New ApproachOcular drug delivery.Drug delivery to the posterior segment of the eye for pharmacologic therapy.Nanogels of methylcellulose hydrophobized with N-tert-butylacrylamide for ocular drug delivery.Nanotechnology-based strategies for treatment of ocular disease.Development and validation of a fast and sensitive bioanalytical method for the quantitative determination of glucocorticoids--quantitative measurement of dexamethasone in rabbit ocular matrices by liquid chromatography tandem mass spectrometry.Ocular delivery of pRNA nanoparticles: distribution and clearance after subconjunctival injection.Solid lipid nanoparticles for ocular drug delivery.In vitro evaluation of a targeted and sustained release system for retinoblastoma cells using Doxorubicin as a model drug.The potential of nanomedicine therapies to treat neovascular disease in the retina.Novel dexamethasone-loaded nanomicelles for the intermediate and posterior segment uveitisOphthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications.Ocular pharmacokinetics of naringenin eye drops following topical administration to rabbitsNanosponge-Mediated Drug Delivery Lowers Intraocular Pressure.Prolonged prevention of retinal degeneration with retinylamine loaded nanoparticles.Sustained release intraocular drug delivery devices for treatment of uveitisDevelopment and characterization of nanoparticulate formulation of a water soluble prodrug of dexamethasone by HIP complexation.Positively charged micelles based on a triblock copolymer demonstrate enhanced corneal penetration.Nanotechnology in corneal neovascularization therapy--a reviewInvestigation of Diffusion Characteristics through Microfluidic Channels for Passive Drug Delivery ApplicationsInnovative pharmaceutical development based on unique properties of nanoscale delivery formulation.The role of blood-ocular barrier transporters in retinal drug disposition: an overview.Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.Ocular drug delivery - a look towards nanobioadhesives.Neovascular age-related macular degeneration: opportunities for development of first-in-class biopharmaceuticals.Nano-vectors for the Ocular Delivery of Nucleic Acid-based Therapeutics.Topical drug delivery to the eye: dorzolamide.Recent overview of ocular patentsNanomaterials for ocular drug delivery.Advances in ocular drug delivery.Prodrug strategies in ocular drug delivery.Ocular drug delivery system: a reference to natural polymers.
P2860
Q26740005-3F91DEDA-2E1D-47B5-8E26-D33912E9F650Q26749178-F7BBE98F-00A4-47A0-B2E0-76548EAAF5A9Q26863420-DE90F7FF-035C-47F2-AE66-C2C714344FA8Q26999057-669F20B8-3085-47C6-AED2-9E58AF994495Q27687657-A2E1EA2E-DC39-41BF-9304-C861E9EFF084Q28479248-AD05E677-4FE3-447B-8BBB-BB328192CF96Q28535125-4166AE13-6CBC-4C44-86C3-715D36B99151Q28538289-B6AB8FC5-7104-498E-AB31-26BBE7DA43E9Q28552701-26FE20DF-0758-4F23-ABD9-E1E31F664466Q30475605-C97B6E17-DCFF-4994-A76D-A9FEA2CC5975Q30478379-09DFAB2C-6298-41E2-ADA1-98F5EF2DAC46Q31140602-5354F3D4-7398-4D75-9A38-243CFCC57D34Q33681543-3A7B3C09-8CE7-4450-AC6A-6834C7BCA2FDQ33782714-9C4B7F35-A33A-4ED8-A715-178E9C8E540DQ34011377-41741D91-A3E1-40FC-A0BB-7ACB34D39FC0Q34116807-65EAECC1-49A6-4520-ABA9-02D9A35D3256Q34206796-D31272CE-8F95-41EB-8EA1-9568E4F8E434Q34220590-35889D34-C08C-4910-88E7-F41691C0ED28Q34265155-9AE720B9-B3D5-419A-93DD-49AE950660CDQ34701929-A18C5DE7-1CC3-407D-AB9C-2BEB9B8123AAQ34862764-0451726B-D704-410B-88DE-DA48D00018BBQ34953629-4D3716EF-C4C8-4314-A264-C429CB4F83B2Q35371767-05BA0D6D-F5EB-4FA6-916F-22470EF91C7CQ35835614-982484B6-9F01-4050-A29E-29AEB93A333EQ35892589-D0681B3C-CC66-4E59-9BE9-EE0A4F242920Q36116578-63AEB3F3-DC56-4C07-AA79-6C82A9304F97Q36696450-5E83F1F4-D4F9-4FD1-B304-5871BF20FA2AQ36985582-30820C78-7A11-45EB-926A-D8B5775DAB3EQ37602017-6FE3415E-D060-4CAD-85BC-D30A19501C5EQ37741227-002BA5D2-A705-4E25-B4A7-2961072EBC78Q37769529-E39F1D0C-3D70-48D5-BE11-A04B2A012CC4Q37822756-2F741522-CB58-4202-847E-E651B419A32FQ37882685-D51396F4-0AE4-45A3-B3A9-5E8AB746796EQ37942156-8DE86689-EBCE-46FB-816C-B615F13BC677Q37978007-98EEFD05-3D4D-4546-B9E5-E0DA5FCDB6FCQ38001747-F30488B0-1D50-4E7C-B2DD-7983B6D4FFC4Q38003088-4AC3DAA7-A421-4CAA-B61A-55C0AB2B50B7Q38003192-D0A01A0E-63B0-4AB3-9B6F-3908914088AAQ38005228-266EFE7C-31BA-4983-8CBF-B2E4AFDC80D8Q38019052-4A25E320-0120-4795-BD61-69446FAEA0CC
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recent perspectives in ocular drug delivery.
@en
Recent perspectives in ocular drug delivery.
@nl
type
label
Recent perspectives in ocular drug delivery.
@en
Recent perspectives in ocular drug delivery.
@nl
prefLabel
Recent perspectives in ocular drug delivery.
@en
Recent perspectives in ocular drug delivery.
@nl
P2093
P2860
P1476
Recent perspectives in ocular drug delivery.
@en
P2093
Ashim K Mitra
Ripal Gaudana
Sai H S Boddu
P2860
P304
P356
10.1007/S11095-008-9694-0
P577
2008-08-29T00:00:00Z